Pharma Vision
3SBio ties up with Ascentage Pharma to develop and commercialize cancer therapeutics PDF Print E-mail
Research and Development
Monday, 15 February 2010 18:00

3SBio Inc, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis.

Read more... [3SBio ties up with Ascentage Pharma to develop and commercialize cancer therapeutics]
 
Blow to Cadila’s H1N1 vaccine plan PDF Print E-mail
Clinical Trials
Sunday, 07 February 2010 18:00

ZydusCadila Pharmaceuticals’ plan to indigenously develop Influenza A HINI (swine flu) vaccine in collaboration with US-based Novavax is likely to be delayed as the government has shown caution in giving go-ahead for the clinical trials.

Read more... [Blow to Cadila’s H1N1 vaccine plan]
 
Dr Reddys completes phase III trials PDF Print E-mail
Clinical Trials
Tuesday, 05 January 2010 18:00

Dr.ReddyPharma major Dr Reddy’s Laboratories Ltd., (DRL), on Monday, announced results from the first phase III trials of its chemical entity, Balaglitazone, an insulin sensitizer used in the treatment of diabetes.

Read more... [Dr Reddys completes phase III trials]
 
TCG Lifesciences, Pfizer ink drug research pact PDF Print E-mail
Research and Development
Tuesday, 05 January 2010 18:00

TCG Lifesciences, the Rs 400-crore clinical research organisation (CRO) venture of the Chatterjee Group, has entered into an exclusive collaboration with the US-based pharma giant, Pfizer, to develop a portfolio of pre-clinical molecules for discovery of new drugs.

Read more... [TCG Lifesciences, Pfizer ink drug research pact]
 
«StartPrev12345678910NextEnd»

Page 1 of 14
Banner
pharmaquest-ezine-logo
Letters and responses
Banner